These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29328435)

  • 1. miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells.
    Liu J; Bi J; Li Z; Li Z; Liu X; Kong C
    Int J Mol Med; 2018 Mar; 41(3):1765-1773. PubMed ID: 29328435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
    Shan H; Zhou X; Chen C
    Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
    Li Y; Zhao L; Qi Y; Yang X
    Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of miR‑214 attenuates the migration and invasion of triple‑negative breast cancer cells.
    Zhang Y; Zhao Z; Li S; Dong L; Li Y; Mao Y; Liang Y; Tao Y; Ma J
    Mol Med Rep; 2019 May; 19(5):4035-4042. PubMed ID: 30942417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
    Wang F; Li L; Chen Z; Zhu M; Gu Y
    Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells.
    Luan T; Fu S; Huang L; Zuo Y; Ding M; Li N; Chen J; Wang H; Wang J
    Exp Cell Res; 2018 Dec; 373(1-2):188-197. PubMed ID: 30463687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
    Dong Q; Fu L; Zhao Y; Tan S; Wang E
    Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
    Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
    BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
    Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
    Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
    PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
    Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
    Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-325 Is a Potential Biomarker and Tumor Regulator in Human Bladder Cancer.
    Lin T; Zhou S; Gao H; Li Y; Sun L
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818790536. PubMed ID: 30176759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway.
    Zhou C; Ding J; Wu Y
    Mol Med Rep; 2014 Apr; 9(4):1467-73. PubMed ID: 24535223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of c-FLIP in cisplatin resistance of human bladder cancer cells.
    Lee S; Yoon CY; Byun SS; Lee E; Lee SE
    J Urol; 2013 Jun; 189(6):2327-34. PubMed ID: 23313194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-194 inhibits cell proliferation and invasion via repression of RAP2B in bladder cancer.
    Zhang M; Zhuang Q; Cui L
    Biomed Pharmacother; 2016 May; 80():268-275. PubMed ID: 27133066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer.
    Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
    Oncol Rep; 2016 Mar; 35(3):1549-56. PubMed ID: 26717965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a negatively regulates Netrin1 and mediates MEK/ERK pathway to regulate chemosensitivity of gastric cancer cells.
    Liu H; Wang L
    Discov Oncol; 2024 Oct; 15(1):563. PubMed ID: 39404782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF21 inhibits proliferation and chemoresistance through the AKT pathway in human gastric cancer.
    Yang Z; Jiang X; Li D; Dong Q; Zhao H; Jiang X
    Gene; 2019 Jan; 682():42-49. PubMed ID: 30296564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
    Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
    Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.